Bone Biologics (BBLG) Shares Outstanding (2010 - 2026)
Bone Biologics (BBLG) posted quarterly Shares Outstanding (Entity) of $1.2 million for Q4 2025, up 364.6% year-over-year from $252878.0 in Q4 2024, and down 34.56% quarter-over-quarter from $1.8 million in Q3 2025.
Powered by 
Analysis
Bone Biologics (BBLG) Shares Outstanding (2010 - 2026) Analysis & Trends
Bone Biologics (BBLG) has reported Shares Outstanding (Entity) for 16 consecutive years, with $1.2 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Shares Outstanding (Entity) rose 364.6% year-over-year to $1.2 million; the TTM figure through Dec 2025 stood at $1.2 million (up 364.6% YoY), while the FY2025 annual figure was $1.2 million, up 364.6% from the prior year.
- Shares Outstanding (Entity) declined to $1.2 million in Q4 2025 per BBLG's latest filing, from $1.8 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $1.8 million in Q3 2025 and bottomed at $2022.0 in Q1 2021.
- Historically, Shares Outstanding (Entity) has averaged $259306.8 across 5 years, with a median of $32835.0 in 2023.
- Annual changes were most pronounced in 2021 — Shares Outstanding (Entity) changed 0.0% — and 2024, when it jumped 905.15%.
- Bone Biologics' Shares Outstanding (Entity) stood at $3154.0 in 2021, then surged by 151.49% to $7932.0 in 2022, then jumped by 452.91% to $43857.0 in 2023, then jumped by 476.6% to $252878.0 in 2024, then surged by 364.6% to $1.2 million in 2025.
- Business Quant data shows BBLG's Shares Outstanding (Entity) at $1.2 million in Q4 2025, $1.8 million in Q3 2025, and $557787.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | 61.30 Mn |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | 210.89 Mn |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 111.58 Mn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 133.61 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 445.06 Mn |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Bone Biologics | 1.00 Mn | 1.00 Mn | - | 1.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.80 Mn |
| Dec 31, 2025 | 1.17 Mn |
| Sep 30, 2025 | 1.80 Mn |
| Jun 30, 2025 | 557,787.00 |
| Mar 31, 2025 | 530,542.00 |
| Dec 31, 2024 | 252,878.00 |
| Sep 30, 2024 | 292,241.00 |
| Jun 30, 2024 | 194,741.00 |
| Mar 31, 2024 | 110,157.00 |
| Dec 31, 2023 | 43,857.00 |
| Sep 30, 2023 | 65,301.00 |
| Jun 30, 2023 | 21,813.00 |
| Mar 31, 2023 | 335,748.00 |
| Dec 31, 2022 | 237,985.00 |
| Sep 30, 2022 | 215,641.00 |
| Jun 30, 2022 | 215,641.00 |
| Mar 31, 2022 | 215,641.00 |
| Dec 31, 2021 | 94,624.00 |
| Sep 30, 2021 | 60,654.00 |
| Jun 30, 2021 | 60,654.00 |